{
  "id": 3499144,
  "title": "Definium Therapeutics to Participate at Upcoming Investor Conferences and Events",
  "url": "https://urgent.news/2026/08/26/definium-therapeutics-to-participate-at-upcoming-investor-conferences",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-26T11:10:44.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/pmn/business-wire-news-releases-pmn/definium-therapeutics-to-participate-at-upcoming-investor-conferences-and-events-2"
  },
  "original_language": "en",
  "account": null,
  "summary": "NEW YORK — Definium Therapeutics, Inc. (Nasdaq: DFTX) (“Definium” or the “Company”), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced that members of the Company’s management team will participate in the following investor conferences and events: Stifel…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}